Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Defined Bioscience

San Diego maker of fully defined, serum-free stem cell media that lower cost and variability for iPSC research and biomanufacturing.

Open the dossier
Opportunities
3
High confidence
070% and above
Counterparts
3startups and investors
  • Customers 1
  • Co-development 1
  • Investors 1

Customers1

Who could buy, or sell through

Design-in before StemSight's clinical process is locked

StemSight is developing iPSC-derived corneal cells with clinical trials targeted around 2027; media choice now will be locked into its regulated process. A collaboration to qualify Defined Bioscience media for its differentiation protocol could create a long-term clinical customer and generate comparative data.

35%confidence

Evidence from the records

  • “Fully defined media formulations with stabilized growth factors, reducing the cost and variability of stem cell culture.”
  • “Corneal cells derived from induced pluripotent stem cells (iPS); clinical trials targeted around 2027.”
If it works
A clinical-stage reference customer and recurring media volume through trials.
First step
Offer StemSight free evaluation kits of HiDef-B8 with a joint comparison protocol.

Co-development1

An integration or joint product

Stem cell culture in microgravity research programmes

G-Space helps biotech companies identify where microgravity offers a commercial advantage and works with Redwire, Voyager and tissue-chip projects. Defined, low-variability media are valuable for space experiments where every run is expensive; a joint offering could put Defined Bioscience into microgravity biomanufacturing studies.

15%confidence

Evidence from the records

  • “Range of 11 media and reagents on sale”
  • “helps biotech and materials companies identify where microgravity offers a commercial advantage and scale up”
  • “NASA SBIR Phase I grant (tissue chips)”
If it works
A niche but high-visibility application and introductions to space-biotech customers.
First step
Ask G-Space which of its clients run stem cell experiments and propose a joint application note.

Investors1

A fund whose thesis fits

Seed round from a science-focused US biotech investor

Defined Bioscience has only an NIH SBIR grant and needs capital for GMP products and sales. KdT invests in US biotech and deep tech from pre-seed to Series A with $0.5–5M tickets and backed ZymoChem in the network.

30%confidence

Evidence from the records

  • “$1.5M (NIH SBIR Phase II grant); no public equity round found”
  • “Biotech & life sciences”
  • “GS Futures, KdT Ventures, Cavallo Ventures (existing investors before the Series A)”
If it works
A first equity round financing GMP development and a commercial team.
First step
Ask ZymoChem's CEO for an introduction to KdT Ventures.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. ORA TechnologieswithPwn&PatchCustomers

    Buy continuous threat-exposure management for the payments stack

    A payment super-app is a prime target for fraud and intrusion, and regulators expect continuous security testing. Pwn&Patch, a North African offensive-security firm with a CTEM platform, can cover attack-surface monitoring and continuous pentesting in French/Arabic, at regional cost. ORA reduces regulatory and breach risk; Pwn&Patch wins a flagship fintech reference in Morocco.

    50%
  2. Pwn&PatchwithORA TechnologiesCustomers

    Win ORA's super-app as a flagship fintech client

    ORA's payment super-app is exposed to regulatory and fraud risk and has no documented security partner. A continuous testing contract gives Pwn&Patch a Moroccan reference in fintech.

    45%
  3. UnitSensewithOrbisCustomers

    Cut Orbis's triple-model interview cost

    Orbis scores every interview with three independent AI models voting by majority, which multiplies inference cost per candidate in a price-sensitive SME market (Jordan, GCC, Egypt). UnitSense's per-request attribution and cheapest-good-enough routing directly targets that cost structure and gives Orbis a per-customer margin view.

    45%
  4. TERAMED SISTEMAS DE SAÚDE, SAwithTIBOKCustomers

    License TIBOK as a white-label engine for Baika

    Instead of building its own stack, Teramed could run Baika+Saúde on TIBOK's white-label OS (own brand, WhatsApp and phone numbers, Portuguese workspace) with pay-per-consultation pricing. It accelerates launch and reduces capex; TIBOK gains an Angolan distributor.

    40%
  5. EqorewithPolyJouleCustomers

    Deploy non-flammable polymer batteries at sensitive sites

    Some industrial sites have strict fire codes; PolyJoule's non-flammable, UL9540A-certified polymer batteries suit them. Eqore gains a differentiated product, PolyJoule a deployment channel.

    40%
  6. FarmbookerwithRegenrateCustomers

    Monitor 1,000+ ha of contracted cover crops

    Regenrate contracts farmers to grow camelina between main crops with a guaranteed price; it must verify sowing, crop development and expected volumes across many farms. Farmbooker's satellite monitoring provides that at scale, as a B2B per-hectare contract.

    40%
  7. PolyJoulewithEqoreCustomers

    Supply non-flammable cells for Eqore's on-site industrial batteries

    Eqore installs behind-the-meter batteries at industrial sites, including heat treatment and die casting where fire risk matters. Both companies are in Massachusetts. PolyJoule's safe chemistry could become Eqore's differentiated option.

    40%
  8. Pulster.aiwithVenditekCustomers

    Optimise Venditek’s vending-machine placement

    Venditek runs about 60 machines in Guatemala and is expanding to Mexico, laundromats and car washes; each misplaced machine is lost capex. Pulster's site-sales prediction, already proven for convenience chains like OXXO, applies directly to micro-locations.

    40%
  9. UnitSensewithKetzaiCustomers

    Unit-cost control for 40,000 teachers on Gemini

    Ketzai serves a large, mostly non-paying teacher base on a paid Gemini plan while its monetisation is unclear; cost per lesson plan is the core margin variable. UnitSense can attribute spend per school/ministry contract and route simpler generations to cheaper models.

    40%
  10. HardshellwithCromodataCustomers

    Certify Cromodata's clinical datasets against leakage and poisoning

    Cromodata sells de-identified clinical data for AI training; buyers will ask for assurance against re-identification and contamination. Hardshell's scans give Cromodata a trust label and Hardshell a commercial, non-defence reference.

    40%
  11. StemSightwithDefined BioscienceCustomers

    Qualify defined, serum-free media for StemSight's manufacturing process

    Moving iPSC-derived cells to the clinic requires defined, low-variability media; Defined Bioscience sells exactly this for pluripotent stem cells. A supply and co-development agreement lowers StemSight's cost of goods and gives Defined Bioscience a clinical-pathway customer.

    40%
  12. Allergen AlertwithNuhproCustomers

    Verified free-from claims for 'Food as Medicine' brands

    Nuhpro sells functional foods targeting intolerances and digestive disorders, where trust in 'free-from' claims is the product. A portable allergen test lets Nuhpro verify batches and co-market verification to consumers, giving Allergen Alert an early B2B design partner.

    35%
  13. CromodatawithLegit.HealthCustomers

    Supply Latin American skin images for model training and validation

    Legit.Health's CE-marked dermatology AI needs diverse skin types for performance and bias validation. Cromodata's imaging-rich network can supply de-identified, labelled datasets, giving Cromodata a named buyer and Legit.Health data for LatAm expansion.

    35%
  14. Defined BiosciencewithStemSightCustomers

    Design-in before StemSight's clinical process is locked

    StemSight is developing iPSC-derived corneal cells with clinical trials targeted around 2027; media choice now will be locked into its regulated process. A collaboration to qualify Defined Bioscience media for its differentiation protocol could create a long-term clinical customer and generate comparative data.

    35%
  15. Monte Caldera Technologies Inc.withSuper Foam Corp.Customers

    Model Super Foam’s PFAS-free formulations in Caldera Engine

    Super Foam casts a patented PFAS-free foam with adjustable formulation and density for each customer part; predicting properties before casting would cut iterations. It is an ideal first case study for Caldera's suspension physics.

    35%
  16. UnitSensewithWiseUnitCustomers

    Voice-agent cost governance for an AI receptionist

    WiseUnit sells a fixed monthly AI receptionist while its voice/LLM costs vary per call; UnitSense explicitly covers voice providers and voice-agent platforms, so it can protect WiseUnit's gross margin per subscriber.

    35%
  17. Neurath AIwithOmniLoc AICustomers

    Confidence bounds for GPS-free positioning

    OmniLoc's AI computes absolute position from camera-to-satellite matching; drone OEMs and defence users need to know when that estimate is unreliable. Neurath's uncertainty quantification can deliver calibrated confidence and identify terrain where more imagery is needed.

    35%
  18. TatraSpacewithTRL11Customers

    Sell flight-software verification to TRL11 ahead of first flight

    TRL11 builds onboard edge-compute video systems with contracts from NASA, Vast and Portal but no documented flight heritage yet, so rigorous ground testing is critical. WisentWire offers remote, CI-integrated testing of firmware against hardware.

    35%
  19. TatraSpacewithAstrolightCustomers

    Firmware testing and payload integration for laser terminals

    Astrolight is moving from test terminals to operational optical-communication networks with ESA and primes; each iteration of terminal firmware needs regression testing. TatraSpace is a nearby Central European supplier with payload-integration experience.

    35%
  20. Piezo Sonic CorporationwithAstrolightCustomers

    Qualify piezo actuators for laser-terminal fine pointing

    Optical terminals need precise, vacuum-compatible fine-pointing and focus mechanisms; ultrasonic motors are a natural fit because they hold position without power and work in vacuum. Astrolight is scaling a terminal product line with ESA and defence customers, so a qualified Japanese actuator source is valuable to it.

    35%

Similar profiles

Compatibility score with Defined Bioscience

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.